Form CORRESP - Correspondence:
SEC Accession No. 0001636282-25-000054
Filing Date
2025-05-21
Accepted
2025-05-21 17:41:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 45687
2 GRAPHIC spyreletterhead.jpg GRAPHIC 17759
  Complete submission text file 0001636282-25-000054.txt   71266
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)